Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination is a topical pharmaceutical product containing an antiseptic (isopropyl alcohol), a nonsteroidal anti-inflammatory drug (ketorolac tromethamine), and a local anesthetic (lidocaine hydrochloride). It is primarily used for localized pain management and pre-procedural skin preparation. Lidocaine hydrochloride functions as a local anesthetic by reversibly blocking voltage-gated sodium channels, thereby inhibiting the initiation and conduction of nerve impulses. Ketorolac tromethamine is a potent analgesic and anti-inflammatory agent that works by non-selectively inhibiting cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which are responsible for the synthesis of prostaglandins involved in pain and inflammation. Isopropyl alcohol serves as a topical antiseptic, denaturing bacterial proteins to reduce the risk of infection at the application site. This synergistic formulation provides rapid numbing, sustained anti-inflammatory effects, and site sterilization, making it particularly useful for minor surgical procedures and musculoskeletal pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isopropyl alcohol + ketorolac tromethamine + lidocaine hydrochloride.